ArticleJournal for immunotherapy of cancer2023

Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE).

Marwan Fakih et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.